Since the outbreak of the COVID-19 pandemic, severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) RNA-dependent RNA polymerase (RdRp) has become a main …

The pandemic caused by the coronavirus SARS-CoV-2 led to a global crisis in the world
healthcare system. Despite some progress in the creation of antiviral vaccines and mass …

Extensive mutations in the Omicron spike protein appear to accelerate the transmission of
SARS-CoV-2, and rapid infections increase the odds that additional mutants will emerge. To …

SARS-COV-2 is responsible for the COVID-19 pandemic, which has infected more than 767
million people worldwide including about 7 million deaths till 5 June 2023. Despite the …

The COVID-19 pandemic has been a major reason behind the increased research aimed at
the identification of effective antiviral agents. Among these, Nucleoside analogs have shown …

Carbon nanotubes (CNTs) have potential prospects in disease treatment, so it is of great
significance to study CNTs as the possible inhibitors of RNA-dependent RNA polymerase …

Фавипиравир, разработанный японскими исследователями в качестве средства
терапии гриппа и других РНК-вирусных инфекций, в 2020-2022 годах стал массово …

The rapid spread and public health impact of the novel SARS-CoV-2 variants that cause
COVID-19 continue to produce major global impacts and social distress. Several vaccines …

Favipiravir, developed by Japanese researchers as a treatment for influenza and other RNA
viral infections, in 2020-2022, has become extensively used in Russia, China, India, Turkey …